Actuate Therapeutics, Inc. Common stock (ACTU) financials · $49.0M cap
Actuate Therapeutics, Inc. Common stock (ACTU) $49.0M cap.
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| Operating Income | -$22.5M | -$25.2M | -$25.0M |
| Net Income | -$22.2M | -$27.3M | -$24.7M |
| EPS (Diluted) | $-1.00 | $-3.00 | $-17.00 |
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | $14.0M | $9.3M | $3.0M |
| Current Assets | $13.6M | $9.2M | $0 |
| Cash & Equivalents | $13.2M | $8.6M | $0 |
| Inventory | $0 | $0 | $0 |
| PP&E | $0 | $0 | $0 |
| Total Liabilities | $6.1M | $9.2M | $8.4M |
| Current Liabilities | $5.7M | $8.8M | $0 |
| Short-term Debt | $0 | $0 | $0 |
| Long-term Debt | $0 | $0 | $0 |
| Total Debt | $0 | $0 | $0 |
| Shareholders' Equity | $7.9M | $104.2K | $0 |
| Retained Earnings | -$154.6M | -$132.4M | $0 |
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Operating Cash Flow | -$19.2M | -$21.8M | -$21.6M |
| CapEx | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 |
| Financing Cash Flow | $23.7M | $27.5M | $4.1M |
| Dividends Paid | $0 | $0 | $0 |
| Net Change in Cash | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 |
FAQ
What is ACTU P/E and revenue?
Actuate Therapeutics, Inc. Common stock (ACTU) $49.0M cap.
What is ACTU revenue?
Actuate Therapeutics, Inc. Common stock last cached revenue is $0 (FY2025).
Is ACTU profitable?
Actuate Therapeutics, Inc. Common stock last cached net income is -$22.2M.
What are ACTU total assets?
Actuate Therapeutics, Inc. Common stock last cached total assets are $14.0M.
What is ACTU free cash flow?
Actuate Therapeutics, Inc. Common stock last cached free cash flow is $0.
Not investment advice. Cached statements, not a live tape.